TG Therapeutics | TGTX - Nettoeinkommen

Aktienkurs
30.07
Täglich Wechseln
-0.29 -0.96%
Monatlich
-1.64%
Jährlich
-30.05%
Q1 Prognose
29.17




Nettoeinkommen Veränderung Datum
AbbVie USD 1.82B 1.63B 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
Amgen USD 1.33B 1.88B 2025-12
Ardelyx USD -407K 562K 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Biogen USD 466.5M 168.3M 2025-09
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Curis USD -11.8M 80K 2024-06
Gilead Sciences USD 2.18B 869M 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
J&J USD 5.12B 36M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Novartis USD 2.41B 1.52B 2025-12
Novavax USD 17.53M 219.91M 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12
Verastem USD -8.26M 25.61M 2024-06
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12